QUALYOP project 2: Monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatients

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue 5, 1999, Pages 331-337

  Barbui, Corrado ^a   D'Avanzo, Barbara ^a   Frattura, Lucilla ^a   Saraceno, Benedetto ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Drug utilization; Psychiatric hospitals; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; DEMENTIA; DEPRESSION; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL HOSPITAL; PERSONALITY DISORDER; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 0032882517     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199908/09)8:5<331::AID-PDS426>3.0.CO;2-H     Document Type: Article

References (28)

1. Saraceno, B., Tognoni, G. Int. J. Social Psychiat. 1989; 35: 98-109.
2. Tansella, M., De Salvia, D., Williams, P. Social Psychiat. 1987; 22: 37-48.
3. Istituto Italiano di Medicina Sociale. L'Assistenza Psichiatrica in Italia: La Normativa e la Diffusione dei Servizi sul Territorio. ISTAT, Rome, 1996.
4. De Salvia, D., Barbato, A. Can. J. Psychiatr. 1993; 38: 195-202.
5. Frattura, L., D'Avanzo, B. Mental Health Care 1998; 1: 334-336.
6. Frattura, L., D'Avanzo, B. Nature Med. 1997; 3: 1054.
7. D'Avanzo, B., Frattura, L., Barbui, C., Civenti, G., Saraceno, B. Int. J. Social Psychiat. 1999; in press.
8. Cosentino, M., Leoni, O., Rispoli, L. et al. Pharmacoepidemiol. Drug Saf. 1996; 5: 377-384.
9. Boiardi, E., Saraceno, B., Guasti, P., Barbui, C. Rivista Sperimentale Freniatria 1996; CXX: 978-1003.
10. Chaplin, R., McGuigan, S. Psychiat. Bull. 1996; 20: 452-454.
11. Tibaldi, G., Munizza, C., Bollini, P. et al. Psychiatr. Serv. 1997; 48: 213-217.
12. Bellantuono, C., Reggi, V., Tognoni, G. et al. In Epidemiological Impact of Psychotropic Drugs, ed. Tognoni, G., Bellantuono, C., Lader, M. Elsevier/North-Holland Biomedical Press, Amsterdam, 1981, 171-181.
13. Anderson, D. N. Br. J. Psychiat. 1989; 154: 644-649.
14. Edwards, S., Kumar, V. Br. J. Psychiat. 1984; 145: 502-507.
15. Muijen, M., Silverstone, T. Br. J. Psychiat. 1987; 150: 501-504.
16. Kiivet, R. A., Llerena, A., Dahl, M. L. et al. Br. J. Clin. Pharmacol. 1995; 40: 467-476.
17. WHO Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC Classification and DDD Assignment, WHO, Oslo, 1996.
18. Barbato, A. Aust. N.Z. J. Psychiat. 1998; 32: 673-679.
19. O'Driscoll, C., Wills, W., Leff, J., Margolius, O. Br. J. Psychiatr. 1993; 162(suppl. 19): 30-35.
20. Leff, J., Thornicroft, G., Coxhead, N., Crawford, C. Br. J. Psychiat. 1994; 165(suppl. 25): 13-17.
21. Ford, M., Goddard, C., Lansdall-Welfare, R. Br. J. Psychiat. 1987; 151: 479-485.
22. McCreadie, R. G., Stewart, M., Robertson, L., Dingwall, J. M. Br. J. Psychiat. 1991; 158: 398-402.
23. Rud, J., Noreik, K. Acta Psychiatr. Scand. 1982; 65: 1-14.
24. Farkas, M., Rogers, E. S., Thurer, S. Hospital Commun. Psychiat. 1987; 38: 864-870.
25. Tognoni, G. Bignami, G. In Epidemiological Impact of Psychotropic Drugs, ed. Tognoni, G., Bellantuono, C., Lader, M. Elsevier/North-Holland Biomedical Press, Amsterdam, 1981, 281-300.
26. Michel, K., Kolakowska, T. Br. J. Psychiat. 1981; 138: 217-221.
27. Horbar, J. D., McAuliffe, T. L., Adler, S. M. et al. Pediatrics 1988; 82: 554-559.
28. The International Neonatal Network. Lancet 1993; 342: 193-198.